Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRACES: Glibenclamide vs Insulin in Gestational Diabetes
NCT02080377Phase 3Completed
- Sponsor
- University of Edinburgh
- Start
- Jul 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glibenclamide in gestational diabetes mellitus (GDM), sponsored by University of Edinburgh. Started Jul 2014; status: completed.
02
Drugs
glibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT02080377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080377.